Peptide-YY, a new partner in the negative feedback control of pancreatic secretion

D. Guan, D. Maouyo, I. L. Taylor, T. W. Gettys, G. H. Greeley, J. Morisset

    Research output: Contribution to journalArticle

    34 Citations (Scopus)

    Abstract

    Peptide YY (PYY), a newly discovered ileocolonic peptide, is released by nutrients in the proximal and distal intestine and inhibits pancreatic secretion. However it is not clear whether PYY can be released in the absence of nutrients in the intestine or whether a physiological role exists for endogenous PYY in negative feedback regulation of pancreatic secretion by pancreatic proteases. In the present study we measured plasma PYY concentrations and determined the effects of anti-PYY serum during stimulation of of pancreatic secretion by pancreatic juice diversion (PJD). The effect of SMS 201-995 (SMS; an analog of somatostatin), another inhibitor of pancreatic secretion, on regulation of PYY release induced by PJD was also investigated. Male Wistar rats equipped with pancreatic, biliary, duodenal, and jugular venous cannulas were studied 4-6 days postoperatively. After 90 min of basal collection, pancreatic juice was diverted for 4 h with or without infusion of SMS1 (2 μg/kg-h), given either iv or intraduodenally (ID). Plasma PYY concentrations were significantly increased from a basal level of 177 ± 15 pg/ml to a peak level of 328 ± 43 pg/ml 2 h after PJD. These increases in PYY concentration paralleled those in Pancreatic protein and fluid outputs. Both iv and ID infusion of SMS during the first 2 h of PJD markedly decreased the plasma PYY concentration to 134 ± 27 pg/ml and 156 ± 19 pg/ml, respectively; the total incremental PYY release during 4 h of PJD was inhibited by 100% and 84% by iv and ID SMS, respectively. One milliliter of anti-PYY serum given iv significantly augmented the increment in protein and fluid output during PJD. These results suggest that endogenous PYY released by PJD may play a physiological role in negative feedback regulation of pancreatic secretion in rats.

    Original languageEnglish (US)
    Pages (from-to)911-916
    Number of pages6
    JournalEndocrinology
    Volume128
    Issue number2
    StatePublished - Feb 1991

    Fingerprint

    Peptide YY
    Pancreatic Juice
    Intestines
    Food
    Octreotide
    Somatostatin
    Serum
    Wistar Rats

    ASJC Scopus subject areas

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism

    Cite this

    Guan, D., Maouyo, D., Taylor, I. L., Gettys, T. W., Greeley, G. H., & Morisset, J. (1991). Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. Endocrinology, 128(2), 911-916.

    Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. / Guan, D.; Maouyo, D.; Taylor, I. L.; Gettys, T. W.; Greeley, G. H.; Morisset, J.

    In: Endocrinology, Vol. 128, No. 2, 02.1991, p. 911-916.

    Research output: Contribution to journalArticle

    Guan, D, Maouyo, D, Taylor, IL, Gettys, TW, Greeley, GH & Morisset, J 1991, 'Peptide-YY, a new partner in the negative feedback control of pancreatic secretion', Endocrinology, vol. 128, no. 2, pp. 911-916.
    Guan D, Maouyo D, Taylor IL, Gettys TW, Greeley GH, Morisset J. Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. Endocrinology. 1991 Feb;128(2):911-916.
    Guan, D. ; Maouyo, D. ; Taylor, I. L. ; Gettys, T. W. ; Greeley, G. H. ; Morisset, J. / Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. In: Endocrinology. 1991 ; Vol. 128, No. 2. pp. 911-916.
    @article{e36bd3fc87814f8bad6d47bd4d645e14,
    title = "Peptide-YY, a new partner in the negative feedback control of pancreatic secretion",
    abstract = "Peptide YY (PYY), a newly discovered ileocolonic peptide, is released by nutrients in the proximal and distal intestine and inhibits pancreatic secretion. However it is not clear whether PYY can be released in the absence of nutrients in the intestine or whether a physiological role exists for endogenous PYY in negative feedback regulation of pancreatic secretion by pancreatic proteases. In the present study we measured plasma PYY concentrations and determined the effects of anti-PYY serum during stimulation of of pancreatic secretion by pancreatic juice diversion (PJD). The effect of SMS 201-995 (SMS; an analog of somatostatin), another inhibitor of pancreatic secretion, on regulation of PYY release induced by PJD was also investigated. Male Wistar rats equipped with pancreatic, biliary, duodenal, and jugular venous cannulas were studied 4-6 days postoperatively. After 90 min of basal collection, pancreatic juice was diverted for 4 h with or without infusion of SMS1 (2 μg/kg-h), given either iv or intraduodenally (ID). Plasma PYY concentrations were significantly increased from a basal level of 177 ± 15 pg/ml to a peak level of 328 ± 43 pg/ml 2 h after PJD. These increases in PYY concentration paralleled those in Pancreatic protein and fluid outputs. Both iv and ID infusion of SMS during the first 2 h of PJD markedly decreased the plasma PYY concentration to 134 ± 27 pg/ml and 156 ± 19 pg/ml, respectively; the total incremental PYY release during 4 h of PJD was inhibited by 100{\%} and 84{\%} by iv and ID SMS, respectively. One milliliter of anti-PYY serum given iv significantly augmented the increment in protein and fluid output during PJD. These results suggest that endogenous PYY released by PJD may play a physiological role in negative feedback regulation of pancreatic secretion in rats.",
    author = "D. Guan and D. Maouyo and Taylor, {I. L.} and Gettys, {T. W.} and Greeley, {G. H.} and J. Morisset",
    year = "1991",
    month = "2",
    language = "English (US)",
    volume = "128",
    pages = "911--916",
    journal = "Endocrinology",
    issn = "0013-7227",
    publisher = "The Endocrine Society",
    number = "2",

    }

    TY - JOUR

    T1 - Peptide-YY, a new partner in the negative feedback control of pancreatic secretion

    AU - Guan, D.

    AU - Maouyo, D.

    AU - Taylor, I. L.

    AU - Gettys, T. W.

    AU - Greeley, G. H.

    AU - Morisset, J.

    PY - 1991/2

    Y1 - 1991/2

    N2 - Peptide YY (PYY), a newly discovered ileocolonic peptide, is released by nutrients in the proximal and distal intestine and inhibits pancreatic secretion. However it is not clear whether PYY can be released in the absence of nutrients in the intestine or whether a physiological role exists for endogenous PYY in negative feedback regulation of pancreatic secretion by pancreatic proteases. In the present study we measured plasma PYY concentrations and determined the effects of anti-PYY serum during stimulation of of pancreatic secretion by pancreatic juice diversion (PJD). The effect of SMS 201-995 (SMS; an analog of somatostatin), another inhibitor of pancreatic secretion, on regulation of PYY release induced by PJD was also investigated. Male Wistar rats equipped with pancreatic, biliary, duodenal, and jugular venous cannulas were studied 4-6 days postoperatively. After 90 min of basal collection, pancreatic juice was diverted for 4 h with or without infusion of SMS1 (2 μg/kg-h), given either iv or intraduodenally (ID). Plasma PYY concentrations were significantly increased from a basal level of 177 ± 15 pg/ml to a peak level of 328 ± 43 pg/ml 2 h after PJD. These increases in PYY concentration paralleled those in Pancreatic protein and fluid outputs. Both iv and ID infusion of SMS during the first 2 h of PJD markedly decreased the plasma PYY concentration to 134 ± 27 pg/ml and 156 ± 19 pg/ml, respectively; the total incremental PYY release during 4 h of PJD was inhibited by 100% and 84% by iv and ID SMS, respectively. One milliliter of anti-PYY serum given iv significantly augmented the increment in protein and fluid output during PJD. These results suggest that endogenous PYY released by PJD may play a physiological role in negative feedback regulation of pancreatic secretion in rats.

    AB - Peptide YY (PYY), a newly discovered ileocolonic peptide, is released by nutrients in the proximal and distal intestine and inhibits pancreatic secretion. However it is not clear whether PYY can be released in the absence of nutrients in the intestine or whether a physiological role exists for endogenous PYY in negative feedback regulation of pancreatic secretion by pancreatic proteases. In the present study we measured plasma PYY concentrations and determined the effects of anti-PYY serum during stimulation of of pancreatic secretion by pancreatic juice diversion (PJD). The effect of SMS 201-995 (SMS; an analog of somatostatin), another inhibitor of pancreatic secretion, on regulation of PYY release induced by PJD was also investigated. Male Wistar rats equipped with pancreatic, biliary, duodenal, and jugular venous cannulas were studied 4-6 days postoperatively. After 90 min of basal collection, pancreatic juice was diverted for 4 h with or without infusion of SMS1 (2 μg/kg-h), given either iv or intraduodenally (ID). Plasma PYY concentrations were significantly increased from a basal level of 177 ± 15 pg/ml to a peak level of 328 ± 43 pg/ml 2 h after PJD. These increases in PYY concentration paralleled those in Pancreatic protein and fluid outputs. Both iv and ID infusion of SMS during the first 2 h of PJD markedly decreased the plasma PYY concentration to 134 ± 27 pg/ml and 156 ± 19 pg/ml, respectively; the total incremental PYY release during 4 h of PJD was inhibited by 100% and 84% by iv and ID SMS, respectively. One milliliter of anti-PYY serum given iv significantly augmented the increment in protein and fluid output during PJD. These results suggest that endogenous PYY released by PJD may play a physiological role in negative feedback regulation of pancreatic secretion in rats.

    UR - http://www.scopus.com/inward/record.url?scp=0025973191&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0025973191&partnerID=8YFLogxK

    M3 - Article

    C2 - 1989869

    AN - SCOPUS:0025973191

    VL - 128

    SP - 911

    EP - 916

    JO - Endocrinology

    JF - Endocrinology

    SN - 0013-7227

    IS - 2

    ER -